Skip to main content

Table 3 Univariate and multivariate Cox regression analyses of risk factors for cancer-related death in early-stage LUAD patients

From: A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations

 

TVGH (N = 69)a

TCGA (N = 299)a

Characteristics

Univariate analysis

Multivariate analysisc

Univariate analysis

 

Multivariate analysisc

HR (95 % CI)b

p-valueb

HR (95 % CI)b

p-valueb

HR (95 % CI)b

p-valueb

HR (95 % CI)b

p-valueb

Eight-probe panel

 Risk < Median

1.00

 

1.00

 

1.00

 

1.00

 

 Risk > Median

2.37 (1.24–4.53)

0.009

2.03 (1.04–3.98)

0.039

1.66 (1.03–2.66)

0.038

1.57 (0.96–2.57)

0.073

Gender

 Male

1.00

 

-

 

1.00

 

-

 

 Female

1.43 (0.71–2.88)

0.321

-

-

0.78 (0.49–1.26)

0.315

-

-

Stage

 Stage IA

1.00

 

1.00

 

1.00

 

1.00

 

 Stage IB

2.13 (0.73–6.16)

0.164

2.01 (0.69–5.86)

0.199

1.15 (0.63–2.11)

0.642

1.17 (0.63–2.16)

0.616

 Stage IIA

8.76 (2.10–36.53)

0.003

5.79 (0.72–46.58)

0.099

2.17 (0.98–4.81)

0.057

0.85 (0.21–3.38)

0.817

 Stage IIB

6.11 (1.81–20.64)

0.003

3.65 (0.70–18.92)

0.124

2.04 (1.07–3.91)

0.031

0.91 (0.26–3.15)

0.885

T stage

 Stage 1–2

1.00

 

-

 

1.00

 

-

 

 Stage 3–4

2.22 (0.53–9.28)

0.277

-

-

0.62 (0.15–2.53)

0.502

-

-

T stage

 Stage 1

1.00

 

-

 

1.00

 

-

 

 Stage 2

1.23 (0.56–2.68)

0.613

-

 

1.28 (0.77–2.12)

0.338

-

 

 Stage 3

2.59 (0.54–12.32)

0.232

-

-

0.72 (0.17–3.07)

0.657

-

-

N stage

 N0

1.00

 

1.00

 

1.00

 

1.00

 

  ≥ N1

3.95 (1.88–8.30)

0.001

1.54 (0.35–6.91)

0.571

2.27 (1.38–3.73)

0.001

2.51 (0.74–8.43)

0.138

Chemotherapy

 No

1.00

 

-

     

 Yes

1.84 (0.92–3.69)

0.084

-

-

    

TKI treatment

 No

1.00

 

-

     

 Yes

2.03 (0.79–5.26)

0.144

-

-

    

Surgery

 Lobectomy

1.00

 

-

     

 Wedge resection

1.35 (0.53–3.45)

0.536

-

     

 Segmentectomy

2.98 (0.40–22.31)

0.288

-

-

    
  1. aTVGH: Taipei Veterans General Hospital; TCGA: The Cancer Genome Atlas
  2. bCI, confidence interval; HR, hazard ratio. Bold values indicate statistical significance (p < 0.05)
  3. cThe variables without significant HR in the univariate analysis were not included in the multivariate analysis